Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Completed

• Conditions: Alpha 1-Antitrypsin Deficiency

• Registration Number: NCT01676688
• Lead Sponsor: Laboratoire français de Fractionnement et de Biotechnologies

Brief Summary

The purpose of this study is to collect safety data on ALFALASTIN® infusions performed at home or in out-of hospital locations.

Detailed Description

Non interventional, observational, longitudinal, prospective, multicenter, non comparative study.

Study Timeline

• Study Start: 2012-01
• Study First Submitted: 2012-08-29
• Study First Submitted QC: 2012-08-30
• Study First Posted: 2012-08-31
• Primary Completion: 2012-09
• Study Completion: 2012-10
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-02
• Last Update Posted: 2023-10-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified